Transcriptomic Evidence of Immune–Tumor Uncoupling Defines a High-Risk State in Uterine Corpus Endometrial Carcinoma
International Journal of Molecular Sciences · 07.05.2026 · 27 (10) · 4170
DOI: 10.3390/ijms27104170 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 07.05.2026. Verfasst von Chia-Hung Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Research, Hsinchu MacKay Memorial Hospital, Hsinchu 30071, Taiwan. Hauptthemen laut MEDLINE: Endometrial Neoplasms, Transcriptome. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Mackay Memorial Hospital, National Science and Technology Council, Hsinchu MacKay Memorial Hospital.
Abstract (Originalsprache)
This study aimed to develop and validate a transcriptomic risk signature for uterine corpus endometrial carcinoma (UCEC) and to investigate whether the identified prognostic program reflects immune–tumor uncoupling within the tumor microenvironment. Using transcriptomic data from The Cancer Genome Atlas (TCGA) UCEC cohort, we identified a 28-gene transcriptomic signature defining a high-risk state. The derived risk score robustly stratified patients into distinct survival groups and remained an independent predictor of overall survival after adjustment for clinical covariates. Functional analyses revealed that high-risk tumors are characterized by a distinct immune–tumor uncoupling phenotype, in which interferon-gamma (IFNG)-associated inflammatory signaling is preserved but fails to translate into effective antitumor immune activity. Specifically, effector immune programs, including CD8 T cell-related signatures and cytotoxic activity, were consistently reduced despite elevated IFNG-associated signaling, indicating a functional discordance between immune activation and immune execution rather than classical T cell exhaustion. In parallel, high-risk tumors exhibited consistently elevated cell cycle and DNA repair-associated transcriptional programs, suggesting that proliferative and stress-adaptive mechanisms represent dominant drivers of poor prognosis. External assessment in an independent GEO cohort (GSE17025) demonstrated consistent associations between signature activity, tumor status, and histological grade, supporting the reproducibility of the underlying transcriptional program at the biological and clinicopathological level. Collectively, this study provides transcriptomic evidence for a previously underappreciated immune–tumor uncoupling state in UCEC and highlights the importance of integrating immune signaling and tumor-intrinsic programs to understand disease progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Research, Hsinchu MacKay Memorial Hospital, Hsinchu 30071, Taiwan.
- Department of Medical Research, Hsinchu Municipal MacKay Children's Hospital, Hsinchu 30068, Taiwan.
- Department of Obstetrics and Gynecology, MacKay Memorial Hospital, Taipei 10449, Taiwan.
- National Center for Instrumentation Research, National Institutes of Applied Research, Hsinchu 30076, Taiwan.
- Department of Medicine, MacKay Medical University, New Taipei 25245, Taiwan.
- Institute of Biomedical Sciences, MacKay Medical University, New Taipei 25245, Taiwan.
ORCID-Profile: Chia-Hung Chen, Chen-Lin Yu, Kai-Yao Huang
Förderung
- Mackay Memorial Hospital
- National Science and Technology Council
- Hsinchu MacKay Memorial Hospital
- the National Science and Technology Council
Zitieren
APA
Chen, C. H., Kao, H. J., Yu, C. L., Weng, T. H., Huang, T. T., Huang, K. Y., & Weng, S. L. (2026). Transcriptomic Evidence of Immune–Tumor Uncoupling Defines a High-Risk State in Uterine Corpus Endometrial Carcinoma. International Journal of Molecular Sciences, 27(10), 4170. https://doi.org/10.3390/ijms27104170
Vancouver
Chen CH, Kao HJ, Yu CL, Weng TH, Huang TT, Huang KY, et al. Transcriptomic Evidence of Immune–Tumor Uncoupling Defines a High-Risk State in Uterine Corpus Endometrial Carcinoma. International Journal of Molecular Sciences. 2026;27(10):4170. doi:10.3390/ijms27104170
BibTeX
@article{Chen2026,
author = {Chen, Chia-Hung and Kao, Hui-Ju and Yu, Chen-Lin and Weng, Tzu-Hsiang and Huang, Tsung-Tao and Huang, Kai-Yao and Weng, Shun-Long},
title = {Transcriptomic Evidence of Immune–Tumor Uncoupling Defines a High-Risk State in Uterine Corpus Endometrial Carcinoma},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {10},
pages = {4170},
doi = {10.3390/ijms27104170}
}
EUVIMED